Stock Analysis

Rare-earths and niobium explorer Aldoro Resources (ASX:ARN) continues advancing its Kameelburg project in Namibia, with exploration activities focused on defining the scale and potential of the critical-minerals asset. The company’s strategy is centred on resource growth, drilling success and evaluating the long-term development potential …

Boutique funds-management group Microequities Asset Management (ASX:MAM) continues managing a portfolio of high-conviction Australian small and micro-cap investment strategies. The company’s financial performance is closely linked to funds under management, market performance and investor appetite for smaller companies.

Gold explorer Waratah Minerals (ASX:WTM) continues progressing the Spur gold project in the Lachlan Fold Belt of New South Wales, with exploration activities focused on defining the scale and continuity of the mineralised system. The company’s growth strategy is centred on drilling success, resource …

Government software company Objective Corporation (ASX:OCL) continues operating as a provider of content and process management solutions for government and regulated organisations. The company’sInvestmentcase has historically been supported by recurring revenue, customer relationships and high-margin software operations, with recent developments placing greater attention on …

Traffic and media company GTN (ASX:GTN) is navigating a challenging operating environment following its FY26 results, which highlighted revenue pressure alongside improved cash generation. The company provides traffic and news content to radio broadcasters and generates revenue through advertising integrated with its content offering.

Rare-earths developer American Rare Earths (ASX:ARR) continues advancing its Halleck Creek project in Wyoming, United States, with the company focused on developing a large-scale rare-earths opportunity. The project forms the foundation of American Rare Earths’ growth strategy, with future value linked to technical studies, …

Medical-device company Epiminder (ASX:EPI) continues progressing its implantable continuous electroencephalography (EEG) monitoring technology for epilepsy, with the company focused on advancing clinical adoption and commercial opportunities. The company’s growth strategy centres on the Minder system, a device designed to provide continuous monitoring for patients …